|
CALL
|
$961,000
|
35K
|
Q4 2024
New holding
|
|
|
CALL
|
$1.23 Million
|
49.5K
|
Q4 2024
Added 65.0%
|
|
|
CALL
|
$1.43 Million
|
49K
|
Q4 2024
Reduced 5.59%
|
|
|
CALL
|
$617,000
|
50K
|
Q3 2024
New holding
|
|
|
PUT
|
$1.03 Million
|
55K
|
Q4 2024
Added 120.0%
|
|
|
CALL
|
$793,000
|
20K
|
Q4 2024
Reduced 33.33%
|
|
|
PUT
|
$1.14 Million
|
116K
|
Q4 2024
Reduced 57.71%
|
|
|
CALL
|
$1.16 Million
|
40K
|
Q4 2024
New holding
|
|
|
PUT
|
$1.22 Million
|
10K
|
Q4 2024
Reduced 82.14%
|
|
|
CALL
|
$1.08 Million
|
29.4K
|
Q4 2024
New holding
|
|
|
CALL
|
$1.11 Million
|
752K
|
Q4 2024
Added 401.53%
|
|
|
PUT
|
$663,000
|
125K
|
Q3 2024
New holding
|
|
|
CALL
|
$577,000
|
122K
|
Q2 2024
New holding
|
|
|
CALL
|
$1.16 Million
|
25K
|
Q4 2024
Reduced 76.1%
|
|
|
CALL
|
$576,000
|
19.6K
|
Q4 2024
Reduced 34.67%
|
|
|
CALL
|
$964,000
|
120K
|
Q4 2024
Reduced 50.0%
|
|
|
CALL
|
$591,000
|
57.1K
|
Q4 2024
Reduced 68.49%
|
|
|
CALL
|
$1.3 Million
|
12.3K
|
Q4 2024
New holding
|
|
|
CALL
|
$1.04 Million
|
40K
|
Q4 2024
Added 25.0%
|
|
|
CALL
|
$1.09 Million
|
135K
|
Q4 2024
New holding
|
|
|
CALL
|
$749,000
|
14K
|
Q4 2024
New holding
|
|
|
PUT
|
$1.26 Million
|
30K
|
Q4 2024
New holding
|
|
|
CALL
|
$1.26 Million
|
30K
|
Q4 2024
New holding
|
|
|
PUT
|
$1.41 Million
|
100K
|
Q4 2024
New holding
|
|
|
PUT
|
$1.16 Million
|
40K
|
Q4 2024
New holding
|
|
|
PUT
|
$622,000
|
164K
|
Q4 2024
New holding
|
|
|
CALL
|
$1.39 Million
|
75K
|
Q4 2024
New holding
|
|
|
PUT
|
$1.17 Million
|
20K
|
Q2 2024
Reduced 63.64%
|
|
|
CALL
|
$1.03 Million
|
20K
|
Q3 2024
New holding
|
|
|
CALL
|
$1.04 Million
|
100K
|
Q4 2024
Added 0.39%
|
|
|
CALL
|
$547,000
|
30K
|
Q4 2024
New holding
|
|
|
PUT
|
$0
|
107K
|
Q4 2024
Added 63.3%
|
|
|
CALL
|
$0
|
75K
|
Q4 2024
Added 63.3%
|
|
|
PUT
|
$0
|
42K
|
Q4 2024
Reduced 26.96%
|
|
|
PUT
|
$0
|
50K
|
Q4 2024
New holding
|
|
Neumora Therapeutics Inc.
|
CALL
|
$0
|
1.52M
|
Q4 2024
New holding
|
|
|
CALL
|
$195,000
|
11K
|
Q4 2024
Added 50.0%
|
|
|
CALL
|
$0
|
41.4K
|
Q4 2024
New holding
|
|
|
CALL
|
$449,000
|
50K
|
Q4 2024
Added 305.71%
|
|
|
CALL
|
$354,000
|
56.3K
|
Q4 2024
Reduced 77.48%
|
|
Avadel Pharmaceuticals PLC
|
CALL
|
$0
|
160K
|
Q4 2024
Added 178.26%
|
|
|
PUT
|
$0
|
200K
|
Q4 2024
New holding
|
|
|
CALL
|
$0
|
42.5K
|
Q4 2024
New holding
|
|
Neumora Therapeutics Inc.
|
PUT
|
$0
|
633K
|
Q4 2024
New holding
|
|
|
CALL
|
$329,000
|
85K
|
Q4 2024
Reduced 50.0%
|
|
|
CALL
|
$0
|
8.8K
|
Q4 2024
Reduced 90.09%
|
|
Bitdeer Technologies Group
|
CALL
|
$0
|
160K
|
Q4 2024
Added 59.5%
|
|
|
CALL
|
$24,000
|
500
|
Q3 2024
Reduced 99.45%
|
|
|
CALL
|
$213,000
|
132K
|
Q4 2024
Added 47.0%
|
|
|
PUT
|
$253,000
|
15K
|
Q4 2024
New holding
|
|